Inhibition of classical pathway of complement activation with negative charged derivatives of bisphenol A and bisphenol disulphates

被引:19
作者
Bureeva, S
Andia-Pravdivy, J
Petrov, G
Igumnov, M
Romanov, S
Kolesnikova, E
Kaplun, A
Kozlov, L
机构
[1] Lomonosov Moscow Acad Fine Chem Technol, Dept Biotechnol, Moscow 119571, Russia
[2] GN Gabrichevskii Epidemiol & Microbiol Res Inst, Moscow 125212, Russia
关键词
complement; inhibitors; QSAR; bisphenol disulphates;
D O I
10.1016/j.bmc.2004.11.056
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to obtain strong inhibitors of classical pathway of complement activation the low weight negative charged compounds have been investigated. On the basis of bisphenol A anionic derivatives with one or two carboxylic, sulphate and phosphate groups the critical role of negative charged groups for complement-inhibiting activity has been established. It was determined that two sulphate or phosphate groups in the molecule provide the most inhibiting effect. At the next stage a set of bisphenol disulphates of varying structures has been synthesized and investigated. Bulky hydrophobic groups (cyclohexyliden, fluorenyliden, anthronyliden) at the central part of the bisphenol molecule it was found to increase complement-inhibiting activity markedly. The replacement of the ortho-positions to the charged group by halogens or alkyl groups (allyl, propyl) increases the inhibiting effect. It was showed by ELISA that several compounds studied interact with Clq, Cl (r) over bar /Cl (s) over bar components of complement. For the set of bisphenol disulphates the QSAR equation with hydrophobic coefficient and electronic parameters has been formulated. Both hydrophobic and electrostatic interactions it was established to have a great significance for the inhibition of classical pathway of complement activation. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1045 / 1052
页数:8
相关论文
共 22 条
[1]  
ASGHAR SS, 1984, PHARMACOL REV, V36, P223
[2]   Synthesis and evaluation of potential complement inhibitory semisynthetic analogs of oleanolic acid [J].
Assefa, H ;
Nimrod, A ;
Walker, L ;
Sindelar, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) :1889-1894
[3]  
Burdelev O. O., 1998, Journal of Liposome Research, V8, P46
[4]   SYNTHETIC PEPTIDE INHIBITORS OF COMPLEMENT SERINE PROTEASES .1. IDENTIFICATION OF FUNCTIONALLY EQUIVALENT PROTEASE INHIBITOR SEQUENCES IN SERPINS AND INHIBITION OF C1S AND D [J].
GLOVER, GI ;
SCHASTEEN, CS ;
LIU, WS ;
LEVINE, RP .
MOLECULAR IMMUNOLOGY, 1988, 25 (12) :1261-1267
[5]   INHIBITION OF HEMOLYTIC COMPLEMENT ACTIVITY BY DERIVATIVES OF BENZAMIDINE [J].
HAUPTMANN, J ;
MARKWARDT, F .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (04) :325-329
[6]   ESTER UND POLYESTER VON PHOSPHORSAURE UND CYCLOALKYLPHOSPHONSAUREN MIT PHENOLEN [J].
HELFERICH, B ;
SCHMIDT, KG .
CHEMISCHE BERICHTE-RECUEIL, 1959, 92 (09) :2051-2056
[7]  
Higgins PJ, 1997, J IMMUNOL, V158, P2872
[8]   COMPLEMENT ACTIVATION AND INHIBITION IN MYOCARDIAL-ISCHEMIA AND REPERFUSION INJURY [J].
HOMEISTER, JW ;
LUCCHESI, BR .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1994, 34 :17-40
[9]   THE EFFECT OF FUT-175 (NAFAMSTAT MESILATE) ON C-3A, C-4A AND C-5A GENERATION INVITRO AND INFLAMMATORY REACTIONS INVIVO [J].
ISSEKUTZ, AC ;
ROLAND, DM ;
PATRICK, RA .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1990, 12 (01) :1-9
[10]  
LI H, 1935, J AM CHEM SOC, V57, P1567